Fibroids Miracle

Uterine Fibroids Treatment Diet

Get Instant Access

1. Egarter CH, Husslein P. (1992). Biochemistry of myometrial contractility. Balliere's Clin Obstet Gynaecol 6: 755-768.

2. Critchley H. (2003). Endometrial effects of progestogens. Gynaecol Forum 8: 6--18.

3. De Swiet M, Chamberlain G. (1994). In: Basic Sciences in Obstetrics and Gynaecology, 2nd edn. Chapter 6 (Physiology), pp. 206-211.

4. The Initial Management of Menorrhagia. Evidence-Based Clinical Guidelines. Royal College of Obstetricians and Gynaecologists.

5. Confidential Enquiry into Maternal Deaths 1996-1999.

6. Waterstone M, Bewley S, Wolfe C. (2001). Incidence and predictors of severe obstetric morbidity-case control study. Br Med J 322: 1089-1093.

7. Manuel G, Buchman E, Rees H, Pattison RG. (1998). Severe acute maternal morbidity: a pilot study of definition of "near miss''. Br J Obstet Gynaecol 105: 985--990.

8. Brace V, Penney G, Hall M. (2004). Br J Obstet Gynaecol 111: 481-484.

9. Department of Health. A First Class Service: Quality in the New NHS. NHS Executive 1998.

10. Greer IA, Lowe GDO, Walker JJ, Forbes CD. (1993). Haemorrhagic problems in obstetrics and gynaecology in patients with congenital coagulopathies. Br J Obstet Gynaecol 98: 909-918.

11. WHO. (1990). The Prevention of Postpartum Haemorrhage (World Health Organisation, Geneva).

12. Drife J. (1997). Management of primary postpartum haemorrhage. Commentary. Br J Obstet Gynaecol 104: 275-277.

13. Tsu VD. (1993). Postpartum haemorrhage in Zimbabwe: a risk factor analysis. Br J Obstet Gynaecol 100: 327-333.

14. Rizvi F, Mackey R, Barrett T, McKenna P, Geary M. (2004). Successful reduction of massive postpartum haemorrhage by use of guidelines and staff education. Br J Obstet Gynaecol 111: 495-498.

15. Gorton H, Lyons G. (1999). Is it time to invest in a thromboelastograph? Int J Obstet Anaesth 8: 171-178.

16. Prendiville W, Elbourne D, Chalmers I. (1998). The effect of routine oxytocic administration in the management of the third stage of labour: an overview of the evidence from controlled trials. Br J Obstet Gynaecol 95: 3-16.

17. Bigrigg A, Chui D, Chissell S, Read MD. (1991). Use of intramyometrial 15-methyl prostaglandin F2 alpha to control atonic postpartum haemorrhage following vaginal delivery and failure of conventional therapy. BrJ Obstet Gynaecol 98: 734--736.

18. El-Refaey H, O'Brien P, Morafa W et al. (1997). Use of oral misoprostol in the prevention of postpartum haemorrhage. Br J Obstet Gynaecol 104: 336--339.

19. El-Refaey H, Nooh R, O'Brien P et al. (2000). The misoprostol third stage of labour study: a randomised controlled comparison between orally administered misoprostol and standard management. Br J Obstet Gynaecol 107: 1104-1110.

20. ChongYS, ChuaS, El-Refaey etal. (2001). Postpartum intrauterine pressure studies of the uterotonic effect of oral misoprostol and intramuscular syntometrine. Br J Obstet Gynaecol 108: 41-47.

21. O'Brien P, El-Refaey H, Gordon A et al. (1998). Rectally administered misoprostol for the treatment of postpartum haemorrhage unresponsive to oxytocin and ergometrine: a descriptive study. Obstet Gynecol 92: 212-214.

22. Bouwmeester FW, Jonkhoff AR, Verheijen RHM, Van Geijn. (2003). Successful treatment of life-threatening postpartum hemorrhage with recombinant activated factor VII. Obstet Gynecol 101: 1174-1176.

23. Branch DW, Rogers GM. (2003). Recombinant activated factor VII: a new weapon in the fight against hemorrhage. 101(6): 1155-1156.

24. Boehlen F, Morales MA, Fontana P et al. (2004). Prolonged treatment of massive postpartum haemorrhage with recombinant factor VIIa: case report and review of the literature. Br J Obstet Gynaecol 111: 284-287.

25. Katesmark M, Brown R, Raju KS. (1994). Successful use of a Sengstaken — Blake-more tube to control massive postpartum haemorrhage. Br J Obstet Gynaecol 101: 259--260.

26. Johanson R, Kumar M, Obhrai M, Young P. (2001). Management of postpartum haemorrhage: use of a hydrostatic balloon to avoid laparotomy. Br J Obstet Gynaecol 108: 420-422.

27. Maier RC. (1993). Control of postpartum haemorrhage with uterine packing. Am J Obstet Gynecol 169: 317-323.

28. B-Lynch C, Coker A, Lawal A et al. (1997). The B-Lynch surgical technique for the control of massive postpartum haemorrhage: an alternative to hysterectomy? Five cases reported. BrJ Obstet Gynaecol 104: 372-375.

29. Danso D, Reginald P. (2002). Combined B-Lynch suture with intrauterine balloon catheter triumphs over massive postpartum haemorrhage. Br J Obstet Gynaecol 109: 963.

30. O'LearyJA. (1995). Uterine artery ligation in the control of postcesarean haemorrhage. JReprod Med 40: 73-74.

31. AbdRabbo SA. (1994). Stepwise uterine devascularisation: a novel technique for management of uncontrollable postpartum haemorrhage with preservation of the uterus. Am J Obstet Gynecol 171: 694-700.

32. Burchell RC. (1964). Internal iliac artery ligation: hemodynamics. Obstet Gynecol 24: 737--739.

33. VedanthamS, Goodwin SC, McLucas B etal. (1997). Uterine artery embolisation: an underused method of controlling pelvic haemorrhage. Am J Obstet Gynecol 176: 938-948.

34. Clark SL, Yeh SY, Phelan JP et al. (1984). Emergency hysterectomy for obstetric haemorrhage. Obstet Gynecol 64: 376-380.

35. Zorlu CG, Turan C, Izik AZ. (1998). Emergency hysterectomy in modern obstetric practice. Acta Obstet Gynecol Scand 77: 186-190.

36. Dildy GA. (2002). Postpartum haemorrhage: new management options. Clin Obstet Gynecol 45(2): 330-334.

37. Clark SL, Koonings PP, Phelan JP. (1985). Placenta previa/accreta and prior cesarean section. Obstet Gynecol 66: 89-92.

38. Lassey AT, Ghosh TS, Wilson JB. (1995). Management of difficult intraoperative bleeding by abdominal packing: report of four cases. East Afr Med J 72(8): 542--543.

39. Higham JM, O'Brien PMS, Shaw RW. (1990). Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 97: 734-739.

40. Reid B, Gangar K. (1994). The medical management of menorrhagia in general practice. TheDiplomate 1: 92-98.

41. Snijders MP, de Goeij AF et al. (1992). Immunocytochemical analysis of oestrogen and progesterone receptors in the human uterus throughout the menstrual cycle and after the menopause. J Reprod Fertil 94: 363-371.

42. Fender GRK, Prentice A, Gorst T et al. (1999). Randomised controlled trial of educational package on management of menorrhagia in primary care: the Anglia menorrhagia education study. Br Med J 318: 1246-1250.

43. Preston JT, Cameron IT, Adams EJ, Smith SK. (1995). Comparative study of tranexamic acid and norethisterone in the treatment of ovulatory menorrhagia. Br J Obstet Gynaecol 102: 401-406.

44. Irvine GA, Campbell-Brown MB, Lumsden MA et al. (1998). Randomised comparative trial of the levonorgestrel intrauterine system and norethisterone for treatment of idiopathic menorrhagia. Br J Obstet Gynaecol 105: 592-598.

45. Duckitt K, Shaw RF. (1998). Is medical management of menorrhagia obsolete? Commentary. Br J Obstet Gynaecol 105: 569-572.

46. Stewart A, Cummins C, Gold L et al. (2001). The effectiveness of the levonorgestrel-releasing intrauterine system in menorrhagia: a systematic review. Br J Obstet Gynaecol 108: 74-86.

47. Bounds W, Robinson G. (1993). Clinical experience with a levonorgestrel releasing intrauterine contraceptive device (LNG-IUD) as a contraceptive and in the treatment of menorrhagia. Br JFam Plann 19: 193-194.

48. Hurskainen R, TeperiJ, Rissanen P et al. (2001). Quality of life and cost effectiveness of levonorgestrel-releasing intrauterine system versus hysterectomy for treatment of menorrhagia: a randomised trial. Lancet 357: 273-277.

49. Sturridge F, GuillbaudJ. (1997). Gynaecological aspects of the levonorgestrel-releasing intrauterine system. BrJ Obstet Gynaecol 104: 285-289.

50. Amso NN, Stabinsky SA, McFaul P et al. (1998). Uterine thermal balloon for the treatment of menorrhagia: the first 300 patients from a multi-centre study. Br J Obstet Gynaecol 105: 517-523.

51. Microsulis Microwave Endometrial Ablation (MEA) System Data.

52. Phillips G, Chien PFW, Garry R. (1998). Risk of hysterectomy after 1000 consecutive endometrial laser ablations. Br J Obstet Gynaecol 105: 897-903.

53. Polet R, Squifflet J, Donnez J. (2003). ELITT: endometrial laser intrauterine thermotherapy. Rv GynaecolPract 3: 51-56.

54. O'Connor H, Magos AL. (1996). Endometrial resection for menorrhagia: evaluation of the results at 5 years. N EnglJ Med 335: 151-156.

55. Cooper KG, Parkin DE, Garratt AM, Grant AM. (1997). A randomised comparison of medical and hysteroscopic management in women, consulting a gynaecologist, for treatment of heavy menstrual loss. Br J Obstet Gynaecol 104: 1360-1366.

56. Overton C, Hargreaves J, Maresh M. (1997). A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Br J Obstet Gynaecol 104: 1351-1359.

57. Khaund A, MossJG, McMillan N, Lumsden MA. (2004). Evaluation of the effect of uterine artery embolisation on menstrual blood loss and uterine volume. Br J Obstet Gynaecol 111: 700-705.

58. Walker WJ, Pelange JP. (2002). Uterine artery embolisation for symptomatic fibroids: clinical results in 400 women with imaging follow-up. BrJ Obstet Gynaecol 109:1262-1272.

59. Prollius A, de Vries C, Loggenberg E et al. (2004). Uterine artery embolisation for symptomatic fibroids: the effect of the large uterus on outcome. Br J Obstet Gynaecol 111: 239-242.

60. Law P, Gedroyc WMW, Regan L. (1999). Magnetic-resonance-guided percutaneous laser ablation of uterine fibroids. Lancet 354: 2049-2050.

61. Crosignani PG, Vercellini P, Meschia M et al. (1996). GnRH agonists before surgery for uterine leiomyomas: a review. J Refrod Med 41(6): 415-421.

62. Lethaby A, Vollenhoven B, Sowter M. (2002). Efficacy of preoperative gonadotrophin hormone releasing analogues for women undergoing hysterectomy or myomectomy: a systematic review. Br J Obstet Gynaecol 109: 1097-1108.

63. Nicholson AA, Turnbull LW, Coady AM, Guthrie K. (1999). Diagnosis and management of uterine arterio-venous malformations. Clin Radiol 54(4): 265-269.


Was this article helpful?

0 0

Post a comment